不出名 发表于 2025-3-23 12:36:54

Mithun Nandyormation games with reachability objectives, here the paths selected by the players need not be simple, thus a player may traverse some transitions several times. Edge costs are shared by the players with the share being proportional to the number of times the transition is traversed. We study the e

Extemporize 发表于 2025-3-23 15:38:36

Mithun Nandyormation games with reachability objectives, here the paths selected by the players need not be simple, thus a player may traverse some transitions several times. Edge costs are shared by the players with the share being proportional to the number of times the transition is traversed. We study the e

ectropion 发表于 2025-3-23 19:42:41

http://reply.papertrans.cn/83/8262/826166/826166_13.png

Frequency 发表于 2025-3-23 22:49:07

http://reply.papertrans.cn/83/8262/826166/826166_14.png

Endearing 发表于 2025-3-24 03:41:02

http://reply.papertrans.cn/83/8262/826166/826166_15.png

limber 发表于 2025-3-24 09:54:17

-art for certain classes of QBF instances, no modern (UN)SAT solver is based on BDDs. For this reason, we initiate the study of interactive certification for more practical SAT algorithms. In particular, we address the question whether interactive protocols can be competitive with some variant of re

deficiency 发表于 2025-3-24 13:12:35

http://reply.papertrans.cn/83/8262/826166/826166_17.png

溃烂 发表于 2025-3-24 15:33:23

tive drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. .978-981-16-6921-7

音的强弱 发表于 2025-3-24 19:25:16

Introduction to Pharmaceutical Marketing Management,

UNT 发表于 2025-3-25 02:01:20

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
页: 1 [2] 3 4
查看完整版本: Titlebook: Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry; Mithun Nandy Book 2022 The Editor(s) (if applicable)